Analyst Ratings for Evolent Health (EVH)
EVH Rating Summary
EVH Price Target Summary
- Highest: $10.00 (Citizens)
- Lowest: $3.00 (RBC Capital)
- Average: $6.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.25 (+39.2%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$6.25 (+39.2%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | KeyBanc | Matthew Gillmor | Downgrade | Sector Weight (Overweight) |
N/A (N/A) |
2.77 (4.49) |
62.09% | Details |
| 11/13/2025 | Stephens | Jeff Garro | Upgrade | Overweight (Equal Weight) |
7.00 (N/A) |
4.45 (4.49) |
0.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
